Immunic, Inc.
IMUX
Revenue
0.00
0.000.00%
-Assets
86.49M
▼-17.66M▼-16.96%
3 Months ChangeLiabilities
22.92M
▲2.34M▲11.37%
3 Months ChangeFree Cash Flow
-24.00M
▼-4.38M▼-22.34%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-22
Form 8-K
ID: 0001193805-24-001257
2024-09-10
Form 8-K
ID: 0001193805-24-001102
2024-09-03
Form 8-K
ID: 0001193805-24-001079
2024-08-08
Form 10-Q
ID: 0001280776-24-000014
2024-08-08
Form 8-K
ID: 0001193805-24-001007
2024-07-24
Form 8-K
ID: 0001193805-24-000957
2024-07-09
Form 8-K
ID: 0001193805-24-000893
2024-06-13
Form 8-K
ID: 0001193805-24-000791
2024-05-08
Form 10-Q
ID: 0001280776-24-000009
2024-05-08
Form 8-K
ID: 0001193805-24-000605